{"url_path":"/sec/mlab/10-k/2026/item-9b","section_key":"item-9b","section_title":"Item 9B Other Information**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/724004/0000724004-26-000047-index.html","accession_number":"0000724004-26-000047","cik":"0000724004","ticker":"MLAB","issuer_name":"MESA LABORATORIES INC /CO/","edgar_url":"https://www.sec.gov/Archives/edgar/data/724004/0000724004-26-000047-index.html","primary_entity_key":"0000724004","primary_entity_name":"MESA LABORATORIES INC /CO/"},"word_count":45,"has_tables":true,"body_markdown":"**Item 9B. Other Information**\n\n \n\nDuring the *three* months ended *March 31, 2026*, none of our directors or officers entered into new or amended written plans for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Exchange Act Rule *10b5*-*1*(c)."}